TY - JOUR
T1 - Continuous Affinity Purification of Adeno-Associated Virus Using Periodic Counter-Current Chromatography
AU - Mendes, João P.
AU - Bergman, Magnus
AU - Solbrand, Anita
AU - Peixoto, Cristina
AU - Carrondo, Manuel J.T.
AU - Silva, Ricardo J.S.
N1 - Funding Information:
Author João Mendes acknowledges Fundação para a Ciência e Tecnologia for PH.D. fellow-ship PD/BD/135502/2018 within the scope of the Ph.D. Program in Bioengineering—Cell Therapies and Regenerative Medicine. The support of iNOVA4Health (UIDB/04462/2020, and UIDP/04462/2020), a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência through national funds, is acknowledged. Funding from Programa INTERFACE through Fundo de Inovação, Tecnologia e Economia Circular (FITEC) is gratefully acknowledged.
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/7
Y1 - 2022/7
N2 - Replacing batch unit operations of biopharmaceuticals by continuous manufacturing is a maturing concept, with periodic counter-current chromatography (PCC) favoured to replace batch chromatography. Continuous affinity capture of adeno-associated virus (AAV) using PCC has the potential to cope with the high doses required for AAV therapies thanks to its inherent high throughput. The implementation of continuous AAV affinity capture using a four-column PCC process is described herein. First, elution buffer screening was used to optimize virus recovery. Second, breakthrough curves were generated and described using a mechanistic model, which was later used to characterize the loading zone of the PCC. The experimental runs achieved a stable cyclic steady state yielding virus recoveries in line with the optimized batch process (>82%), with almost a three-fold improvement in productivity. The PCC affinity capture process developed here can bolster further improvements to process economics and manufacturing footprint, thereby contributing to the integrated continuous manufacturing concept.
AB - Replacing batch unit operations of biopharmaceuticals by continuous manufacturing is a maturing concept, with periodic counter-current chromatography (PCC) favoured to replace batch chromatography. Continuous affinity capture of adeno-associated virus (AAV) using PCC has the potential to cope with the high doses required for AAV therapies thanks to its inherent high throughput. The implementation of continuous AAV affinity capture using a four-column PCC process is described herein. First, elution buffer screening was used to optimize virus recovery. Second, breakthrough curves were generated and described using a mechanistic model, which was later used to characterize the loading zone of the PCC. The experimental runs achieved a stable cyclic steady state yielding virus recoveries in line with the optimized batch process (>82%), with almost a three-fold improvement in productivity. The PCC affinity capture process developed here can bolster further improvements to process economics and manufacturing footprint, thereby contributing to the integrated continuous manufacturing concept.
KW - adeno-associated virus
KW - affinity purification
KW - continuous processing
KW - gene therapy
KW - periodic counter-current chromatography
UR - http://www.scopus.com/inward/record.url?scp=85133294938&partnerID=8YFLogxK
U2 - 10.3390/pharmaceutics14071346
DO - 10.3390/pharmaceutics14071346
M3 - Article
AN - SCOPUS:85133294938
SN - 1999-4923
VL - 14
JO - Pharmaceutics
JF - Pharmaceutics
IS - 7
M1 - 1346
ER -